How has been the historical performance of Nukleus Office?

Nov 13 2025 12:44 AM IST
share
Share Via
Nukleus Office experienced significant growth from March 2024 to March 2025, with net sales increasing from 17.13 Cr to 28.71 Cr and profit after tax rising from 1.20 Cr to 2.06 Cr. Key metrics such as operating profit margin and earnings per share also improved, indicating a strong upward trend in financial performance.
Answer:
The historical performance of Nukleus Office shows significant growth from March 2024 to March 2025.

Breakdown:
In the standalone annual results, Nukleus Office reported net sales of 28.71 Cr in March 2025, a substantial increase from 17.13 Cr in March 2024. The total operating income mirrored this growth, rising to 28.71 Cr from 17.13 Cr. Total expenditure also increased, reaching 22.20 Cr in March 2025 compared to 13.89 Cr in the previous year. Consequently, the operating profit (PBDIT) rose to 6.65 Cr from 3.28 Cr, with a notable operating profit margin of 22.68% in March 2025, up from 18.91%. Profit before tax improved to 2.74 Cr from 1.60 Cr, leading to a profit after tax of 2.06 Cr, compared to 1.20 Cr in March 2024. The earnings per share (EPS) increased to 5.11 from 4.76, while the book value per share surged to 97.4 from 16.66. On the balance sheet, total assets grew to 58.84 Cr from 19.08 Cr, and total liabilities rose to 58.84 Cr from 19.08 Cr. The cash flow from financing activities saw a significant increase to 34.00 Cr in March 2025 from 8.00 Cr in March 2024, contributing to a net cash inflow of 18.00 Cr, up from 5.00 Cr. Overall, these metrics reflect a robust upward trend in the financial performance of Nukleus Office.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
When is the next results date for Nukleus Office?
Nov 07 2025 11:21 PM IST
share
Share Via
Why is Nukleus Office falling/rising?
Oct 25 2025 12:31 AM IST
share
Share Via
Is Nukleus Office overvalued or undervalued?
Sep 30 2025 08:05 AM IST
share
Share Via
Why is Nukleus Office falling/rising?
Sep 22 2025 11:59 PM IST
share
Share Via
Why is Nukleus Office falling/rising?
Sep 19 2025 11:55 PM IST
share
Share Via
Why is Nukleus Office falling/rising?
Sep 18 2025 11:58 PM IST
share
Share Via
Why is Nukleus Office falling/rising?
Sep 16 2025 11:49 PM IST
share
Share Via